LEQEMBI

NDC 62856-212 · Eisai Inc.

Generic namelecanemab

Dosage formINJECTION, SOLUTION

RouteINTRAVENOUS

Active ingredient(s)LECANEMAB

Strength100 mg/mL

Pharmacologic classAmyloid Beta-directed Antibody Interactions [MoA], Amyloid Beta-directed Antibody [EPC]

Marketing categoryBLA

Packages

62856-212-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (62856-212-01) / 2 mL in 1 VIAL, SINGLE-DOSE

J0174 — Lecanemab-irmb, for intravenous injection, 1 mg Medicare Part B payment limit (ASP + 6%): $1.34

FDA lists these products with the same active ingredient.

62856-215 — lecanemab

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.